Disease activity and treatment patterns in rheumatoid arthritis in Qatar: Data from the Qatar rheumatoid arthritis registry
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 4
Abstract
Introduction/Objectives: To describe disease activity and treatment patterns in patients with rheumatoid arthritis in Qatar. Methods: Registry data from consecutive patients who attended routine rheumatology outpatient clinic appointments at the Hamad General Hospital between June 2013 and September 2015 were evaluated. Results: Data on 496 patients (female, 75.8%) were analyzed: 75.6% were rheumatoid factor positive, 79.6% were anti-cyclic citrullinated peptide positive, and 30.6% had erosive arthritis at data collection. Methotrexate (MTX) was the most commonly prescribed synthetic DMARD (in 65.3%): 27% monotherapy, 20.8% combined with hydroxychloroquine or sulfasalazine or leflunomide, and 4.2% triple therapy. Hydroxychloroquine, sulfasalazine, or leflunomide were used by 29.4%, 21.2%, and 13.7% of patients, respectively; <5% of patients used these drugs as monotherapy. One quarter of patients (26.4%) were receiving biologic drugs (etanercept, 9.3%; rituximab, 6%; tocilizumab, 5.6%; adalimumab, 4.4%; abatacept, 0.4%; certolizumab, 0.4%; infliximab, 0.2%). Among patients who were receiving biologic therapy, 32% were on monotherapy. Patients' disease activity status was found to vary according to the employed measure of disease activity, with greater proportions of patients in remission reported using the Disease Activity Score 28 (30.3%) vs. Clinical Disease Activity Index (18%) and the Simple Disease Activity Index (17.5%). Conclusion: Treatment patterns in RA patients in Qatar are similar to those reported in registries worldwide. Therapy commonly includes MTX with an increasing number of patients being on biologic medications. Disease activity status varies according to methodology.
Authors and Affiliations
Fiaz Alam, Mohammed Hammoudeh, Hani Malallah Abdulaziz, Housam Aldeen Sarakbi, Abdul Rahim Mohammed Siam, Salah Mohamed Mehdi, Izzat Ali Mohamed Khanjar, Nabeel Abdulla, Abdo Qaid Lutf, Eman Hassan Satti El Sayed, Shaymaa El Atwy, Samar Al Emadi
Keywords
Related Articles
- EP ID EP604588
- DOI -
- Views 54
- Downloads 0
Synovial fluid level of vascular endothelial growth factor (VEGF) can predict functional status and radiological severity in patients with knee osteoarthritis (OA)
Aim of the work: Detection of serum and synovial fluid level of Vascular Endothelial Growth Factor (VEGF) in patients with knee osteoarthritis (OA) and to determine its relation to radiological severity and function stat...
Peripheral blood biomarkers in systemic sclerosis -associated interstitial lung diseases
Interstitial lung disease (ILD) can lead to significant morbidity and excess mortality in systemic sclerosis (SSc) patients. The early identification of patients at risk of progressive ILD is the main challenges for trea...
Influence of single nucleotide polymorphisms on the efficacy of platelet-rich plasma in the treatment of injuries
Tissue repair in musculoskeletal injuries is often a slow and sometimes incomplete process. Musculoskeletal injuries have a great impact on athletes’ especially elite athletes – and a rapid recovery of full efficiency an...
Hyperuricemia as an independent predictor and prognostic factor in the development of lupus nephritis
Background: Lupus nephritis (LN) can increase morbidity and mortality risk in systemic lupus erythematosus (SLE) and 25% of the patients with LN will advance to end-stage renal disease. Objective: To evaluate if hyperuri...
Severe infusion reactions to tocilizumab in young children with systemic juvenile idiopathic arthritis
Objective: Tocilizumab (TCZ) is the first-line agent against systemic juvenile idiopathic arthritis (sJIA) refractory to glucocorticoids. However, some patients discontinue TCZ because of severe infusion reactions (IRs)....